Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting Naltrexone for Pre-release Prisoners
NCT02867124Phase 3Completed
- Sponsor
- Friends Research Institute
- Start
- Jan 2017
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in opioid use disorder (OUD), sponsored by Friends Research Institute. Started Jan 2017; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02867124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867124.